| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anakinra for the treatment of adult secondary HLH: a retrospective experience
|
Naymagon, Leonard
|
|
|
116 |
6 |
p. 947-955
|
artikel
|
| 2 |
A novel RARA–SNX15 fusion in PML–RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1)
|
Hirade, Kentaro
|
|
|
116 |
6 |
p. 956-960
|
artikel
|
| 3 |
Biological and clinical significance of epigenetic alterations in B-cell lymphomas
|
Ennishi, Daisuke
|
|
|
116 |
6 |
p. 821-827
|
artikel
|
| 4 |
Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study
|
Ono, Takaaki
|
|
|
116 |
6 |
p. 871-882
|
artikel
|
| 5 |
Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients
|
Oyama, Takashi
|
|
|
116 |
6 |
p. 966-972
|
artikel
|
| 6 |
Clinical diagnostic accuracy of respiratory failure in critically ill hematopoietic stem cell transplant patients
|
Barua, Reeta
|
|
|
116 |
6 |
p. 929-936
|
artikel
|
| 7 |
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma
|
Shimano, Rena
|
|
|
116 |
6 |
p. 856-862
|
artikel
|
| 8 |
Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
|
Kawabata, Hiroshi
|
|
|
116 |
6 |
p. 976-977
|
artikel
|
| 9 |
Epigenetics in lymphocyte and lymphoma: EZH2 as an easy-to-access therapeutic target?
|
Kato, Koji
|
|
|
116 |
6 |
p. 819-820
|
artikel
|
| 10 |
Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study
|
Kawabata, Hiroshi
|
|
|
116 |
6 |
p. 846-855
|
artikel
|
| 11 |
Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia
|
Hagino, Takeshi
|
|
|
116 |
6 |
p. 961-965
|
artikel
|
| 12 |
Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients
|
Cabrera-Garcia, David
|
|
|
116 |
6 |
p. 937-946
|
artikel
|
| 13 |
Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1
|
Han, Lijie
|
|
|
116 |
6 |
p. 892-901
|
artikel
|
| 14 |
Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin–aldosterone–angiotensin system inhibitors in patients with chronic myelogenous leukemia
|
Tsuda, Mariko
|
|
|
116 |
6 |
p. 863-870
|
artikel
|
| 15 |
Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience
|
Spałek, Adrianna
|
|
|
116 |
6 |
p. 922-928
|
artikel
|
| 16 |
Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia
|
Aydin, Semra
|
|
|
116 |
6 |
p. 883-891
|
artikel
|
| 17 |
The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy
|
Wang, Ying
|
|
|
116 |
6 |
p. 837-845
|
artikel
|
| 18 |
Therapy-related myeloid neoplasms of recipient origin after allogeneic hematopoietic stem cell transplantation for acute leukemia
|
Hoshino, Takumi
|
|
|
116 |
6 |
p. 902-910
|
artikel
|
| 19 |
The role of epigenetics in T-cell lymphoma
|
Yamagishi, Makoto
|
|
|
116 |
6 |
p. 828-836
|
artikel
|
| 20 |
Ultrasonographic monitoring of sinusoidal obstruction syndrome in patients treated with inotuzumab ozogamicin
|
Iwai, Takahito
|
|
|
116 |
6 |
p. 973-975
|
artikel
|
| 21 |
Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin’s lymphoma: an open-label, multicenter, dose-escalation phase 1 study
|
Goto, Hideki
|
|
|
116 |
6 |
p. 911-921
|
artikel
|
Tijdschrift beschrijving